Synchronicity Pharma
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
750 Battery St Ste 400, San Francisco, C...Phone Number
(650) 235-4140Website
www.synchronicitypharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Synchronicity Pharma
Synchronicity Pharma is a genetic medicines company focused on developing first-in-class, non-viral, targeted nucleic acid therapeutics through its proprietary gene monoclonal antibody (GMAB) platform technology. The company specializes in circadian medicine, creating novel therapeutics for sleep-wake disorders linked to neurodivergence and challenging cancers. Founded by leading experts in circadian biology, Synchronicity Pharma aims to advance the understanding and treatment of these conditions. Their innovative approach seeks to address significant unmet medical needs in both cancer treatment and circadian rhythm disorders.Explore more
Popular SearchesSynchronicity Pharma IncSynchronicity PharmaSynchronicitypharma.comSIC Code 87,873NAICS Code 54,541Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Synchronicity Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Synchronicity Pharma had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Synchronicity Pharma has new funding data
Earning: See what the market has to say on Synchronicity Pharma recently announced quarterly report
Check out if Synchronicity Pharma is spiking on competitors!
Product Launch: Get notified when Synchronicity Pharma launches new products
Congratulate Masked Content for being promoted to Masked Content at Synchronicity Pharma
Synchronicity Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Synchronicity Pharma has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Synchronicity Pharma
Compare insights from companies similar to Synchronicity Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Synchronicity Pharma
<$5M
11-50
Private
$38.8M
2008
N/A
Company Profile Activity
Activity Insights
Synchronicity Pharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Synchronicity Pharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Synchronicity Pharma.
Synchronicity Pharma financials insights
Gather financial insights about Synchronicity Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Debt
$9.1M
2016
Private Equity
$29.7M
Synchronicity Pharma Tech Stack
A closer look at the technologies used by Synchronicity Pharma
Synchronicity Pharma News & Media
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Synchronicity Pharma
Sign Up For FreeTo access detailed company insights
Synchronicity Pharma is a genetic medicines company focused on developing first-in-class, non-viral, targeted nucleic acid therapeutics through its proprietary gene monoclonal antibody (GMAB) platform technology. The company specializes in circadian medicine, creating novel therapeutics for sleep-wake disorders linked to neurodivergence and challen... Read More
